Annual Current Liabilities
$1.91 M
-$3.65 M-65.61%
December 31, 2024
Summary
- As of March 14, 2025, REVBW annual total current liabilities is $1.91 million, with the most recent change of -$3.65 million (-65.61%) on December 31, 2024.
- During the last 3 years, REVBW annual current liabilities has fallen by -$228.01 thousand (-10.65%).
- REVBW annual current liabilities is now -65.61% below its all-time high of $5.56 million, reached on December 31, 2023.
Performance
REVBW Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.91 M
-$2.15 M-52.94%
December 31, 2024
Summary
- As of March 14, 2025, REVBW quarterly total current liabilities is $1.91 million, with the most recent change of -$2.15 million (-52.94%) on December 31, 2024.
- Over the past year, REVBW quarterly current liabilities has dropped by -$2.15 million (-52.94%).
- REVBW quarterly current liabilities is now -82.80% below its all-time high of $11.13 million, reached on June 30, 2024.
Performance
REVBW Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
REVBW Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.6% | -52.9% |
| 3 y3 years | -10.7% | -52.9% |
| 5 y5 years | +58.3% | -52.9% |
REVBW Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.6% | at low | -82.8% | at low |
| 5 y | 5-year | -65.6% | +58.3% | -82.8% | at low |
| alltime | all time | -65.6% | +58.3% | -82.8% | at low |
Revelation Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.91 M(-65.6%) | $1.91 M(-52.9%) |
| Sep 2024 | - | $4.07 M(-63.5%) |
| Jun 2024 | - | $11.13 M(+112.9%) |
| Mar 2024 | - | $5.23 M(-6.0%) |
| Dec 2023 | $5.56 M(+25.0%) | $5.56 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.45 M(+107.8%) | - |
| Jun 2022 | - | $6.00 M(-25.8%) |
| Mar 2022 | - | $8.08 M(+277.2%) |
| Dec 2021 | $2.14 M(+77.2%) | $2.14 M(-3.3%) |
| Sep 2021 | - | $2.21 M |
| Dec 2020 | $1.21 M | - |
FAQ
- What is Revelation Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Revelation Biosciences?
- What is Revelation Biosciences annual current liabilities year-on-year change?
- What is Revelation Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Revelation Biosciences?
- What is Revelation Biosciences quarterly current liabilities year-on-year change?
What is Revelation Biosciences annual total current liabilities?
The current annual current liabilities of REVBW is $1.91 M
What is the all time high annual current liabilities for Revelation Biosciences?
Revelation Biosciences all-time high annual total current liabilities is $5.56 M
What is Revelation Biosciences annual current liabilities year-on-year change?
Over the past year, REVBW annual total current liabilities has changed by -$3.65 M (-65.61%)
What is Revelation Biosciences quarterly total current liabilities?
The current quarterly current liabilities of REVBW is $1.91 M
What is the all time high quarterly current liabilities for Revelation Biosciences?
Revelation Biosciences all-time high quarterly total current liabilities is $11.13 M
What is Revelation Biosciences quarterly current liabilities year-on-year change?
Over the past year, REVBW quarterly total current liabilities has changed by -$2.15 M (-52.94%)